Production and prophylactic efficacy study of human papillomavirus-like particle expressing HPV16 L1 capsid protein

Cited 0 time in scopus
Metadata Downloads

Full metadata record

DC FieldValueLanguage
dc.contributor.authorJie Yun Park-
dc.contributor.authorHyun Mi Pyo-
dc.contributor.authorSun Woo Yoon-
dc.contributor.authorSun Young Baek-
dc.contributor.authorSue Nie Park-
dc.contributor.authorC J Kim-
dc.contributor.authorHa Ryoung Poo-
dc.date.accessioned2017-04-19T08:59:30Z-
dc.date.available2017-04-19T08:59:30Z-
dc.date.issued2002-
dc.identifier.issn1225-8873-
dc.identifier.urihttps://oak.kribb.re.kr/handle/201005/6005-
dc.description.abstractTo perform the prophylactic study of a vaccine derived from human papillomavirus (HPV) using Balb/c mice, we produced virus like particles consisting of HPV capsid protein L1 which has been reported to induce significant humoral and cellular immunity using various animal model systems. In order to produce HPV16 VLPs, the cDNA of L1 capsid protein in HPV type 16, obtained by polymerase chain reaction, was inserted into yeast expression vector, YEGα-HIR525 under the control of GAL10 promoter. The transformation of YEGα-HPV16 L1 was performed into the yeast Saccharomyces cerevisiae Y2805 by the lithium acetate method and the yeast clone expressing the highest level of L1 capsid protein of human papillomavirus type 16 was selected by Western blot analysis using anti-HPV16 L1 antibody. The purification of HPV16 VLP has been performed by the ultracentrifugation and gel-filtration methods. To validate the vaccine efficacy of the purified HPV16 VLPs and investigate the properties of HPV16 VLPs to induce humoral immunity, ELISA assay was performed. A significantly increased production of anti-HPV16 VLP antibodies was observed in sera from immunized mice. The neutralization activity of antibodies in the sera from the vaccinated mice was demonstrated by a rapid and simple assay to detect hemagglutihation inhibition activity.-
dc.publisherMicrobiological Society Korea-
dc.titleProduction and prophylactic efficacy study of human papillomavirus-like particle expressing HPV16 L1 capsid protein-
dc.title.alternativeProduction and prophylactic efficacy study of human papillomavirus-like particle expressing HPV16 L1 capsid protein-
dc.typeArticle-
dc.citation.titleJournal of Microbiology-
dc.citation.number4-
dc.citation.endPage318-
dc.citation.startPage313-
dc.citation.volume40-
dc.contributor.affiliatedAuthorJie Yun Park-
dc.contributor.affiliatedAuthorHyun Mi Pyo-
dc.contributor.affiliatedAuthorSun Woo Yoon-
dc.contributor.affiliatedAuthorSue Nie Park-
dc.contributor.affiliatedAuthorHa Ryoung Poo-
dc.contributor.alternativeName박지연-
dc.contributor.alternativeName표현미-
dc.contributor.alternativeName윤선우-
dc.contributor.alternativeName백선영-
dc.contributor.alternativeName박순희-
dc.contributor.alternativeName김철중-
dc.contributor.alternativeName부하령-
dc.identifier.bibliographicCitationJournal of Microbiology, vol. 40, no. 4, pp. 313-318-
dc.subject.keywordcapsid protein-
dc.subject.keywordhemagglutination inhibition-
dc.subject.keywordhuman papillomavirus (HPV)-
dc.subject.localcapsid protein-
dc.subject.localhemagglutination inhibition-
dc.subject.localHemagglutination inhibition-
dc.subject.localhuman papillomavirus (HPV)-
dc.subject.localHuman papillomavirus-
dc.subject.localhuman paillomavirus(HPV)-
dc.subject.localhuman papillomavirus-
dc.subject.localHuman papillomavirus (HPV)-
dc.subject.localhuman papilloma virus (HPV)-
dc.subject.localHPV-
dc.description.journalClassY-
Appears in Collections:
Division of Research on National Challenges > Bionanotechnology Research Center > 1. Journal Articles
Division of Research on National Challenges > Infectious Disease Research Center > 1. Journal Articles
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.